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Polychlorinated biphenyls (PCBs) are wide-
spread, persistent environmental toxicants
that have been associated, particularly during
development, with behavioral deﬁcits in both
humans and experimental animals (Jacobson
and Jacobson 1996; Patandin et al. 1999;
Roegge et al. 2000; Stewart et al. 2000) and
with changes in biochemical and neurochem-
ical function (Eriksson 1998; Goldey et al.
1995; Seegal et al. 1997).
The effects of PCB exposure on neuro-
chemical function have been most extensively
studied for the neurotransmitter dopamine
(DA). Using pheochromocytoma (PC12)
cells, we demonstrated that only noncoplanar
PCB congeners significantly decreased cell
DA content (Shain et al. 1991). Similar
decreases in tissue DA content were described
by Chishti et al. (1996) and by Bemis and
Seegal (1999) after ex vivo exposure of striatal
slices from adult rats to commercial mixtures
of PCBs. These decreases in tissue DA con-
tent after acute exposure were accompanied
by signiﬁcant elevations in media DA, which
led us to suggest that PCBs either enhance
release of DA and/or inhibit transport of the
neurotransmitter back into the neuron.
Similar results have also been seen by other
investigators; Messeri et al. (1997) reported
increased release of catecholamines into
medium after exposure of bovine adrenal
chromaffin cells to the noncoplanar PCB
congener 2,4,2´,4´-tetrachlorobiphenyl
(TCB) but not to the tetrachlorinated copla-
nar congener 3,4,3´,4´-TCB.
These elevations in media DA concentra-
tions may involve PCB-mediated inhibition
of the membrane dopamine transporter
(DAT). Indeed, Rosin and Martin (1981)
reported significant reductions in uptake of
biogenic amine neurotransmitters into
synaptosomes after exposure to Aroclor mix-
tures, whereas Mariussen and Fonnum
(2001) recently reported that only noncopla-
nar PCB congeners inhibited uptake of
labeled DA into striatal synaptosomes. Taken
together, these findings from disparate neu-
ronal preparations suggest that noncoplanar
PCB congeners affect the release and/or
uptake of neurotransmitters, DA in particu-
lar, that play important roles in mediating
behavior (Arnsten 1997; Sokolowski and
Salamone 1994).
However, the above-mentioned neuro-
chemical studies are in vitro studies and, to the
best of our knowledge, no studies have deter-
mined whether these ﬁndings can be extrapo-
lated to the more complex in vivo neuronal
environment. We therefore exposed adult
male rats to a commercial mixture of PCBs
(Aroclor 1254) and used in vivo microdialysis
to determine extraneuronal (i.e., dialysate)
concentrations of DA. Furthermore, to deter-
mine whether these changes in dialysate DA
concentrations provide a more sensitive index
of altered DA function than do changes in
postmortem tissue DA concentrations, we
measured striatal tissue DA concentrations in
male rats of the same age, exposed to PCBs for
identical periods of time.
Materials and Methods
Animals. Experimental subjects consisted of
adult male Sprague-Dawley–derived rats
either from the breeding facilities of the New
York State Department of Health or from
Taconic Farms (Germantown, NY). No sta-
tistical differences in body weight or neuro-
chemical responses to PCBs were detected
between the Sprague-Dawley rats from the
two different sources.
Animals were approximately 12 weeks of
age before their initial exposure to PCBs and
were housed singly in plastic cages (45 × 24 ×
16.5 cm) with Sani-Chips heat-treated bed-
ding (P.J. Murphy Forest Products, Montville,
NJ) in a secure facility maintained at 23°C on
a 12-hr light:12-hr dark schedule. There were
three or four PCB-exposed and control ani-
mals at each exposure period for in vivo micro-
dialysis, and three to six PCB-exposed and
control animals at each exposure period for
determination of postmortem striatal tissue
DA concentrations.
PCBs. Aroclor 1254 was obtained from
the Wadsworth Center, New York State
Department of Health, and was analyzed by
high-resolution mass spectrometry (O’Keefe et
al. 1985) for polychlorinated dibenzofurans
(PCDFs) and polychlorinated dibenzo-p-diox-
ins (PCDDs). Total PCDFs were 22.4 ppm,
and no PCDDs were found at detection limits
of 0.3 ppb.
Exposure of animals to PCBs. We provided
each animal with one-half of a vanilla wafer
cookie containing a sufficient amount of
Aroclor 1254 dissolved in corn oil to result in a
daily PCB exposure of 25 mg/kg/day. Animals
were exposed on a daily basis to either Aroclor
1254 (PCB-exposed) or corn oil (control) for 3
days or 1, 2, or 8 weeks. We have used this pro-
cedure in the past (Seegal et al. 1997) and have
found that it is a nonstressful means of provid-
ing a known quantity of PCBs to the animal.
This procedure was used for all animals,
including those that underwent microdialysis
and those sacrificed for determination of 
Address correspondence to R.F. Seegal, Wadsworth
Center, New York State Department of Health,
Empire State Plaza, Albany, NY 12201 USA.
Telephone: (518) 473-4378. Fax: (518) 486-1505.
E-mail: seegal@wadsworth.org
Research support for this work was provided in
part by National Institute of Environmental Health
Sciences grant ES07921 and U.S. Environmental
Protection Agency grant R825812 to R.F.S.
Received 14 February 2002; accepted 9 April 2002.
Articles
Polychlorinated biphenyls (PCBs) reduce tissue dopamine (DA) concentrations and increase
media DA concentrations in both in vitro preparations of bovine adrenal chromaffin cells and
adult rat striatal tissue. To determine whether these changes also occur in the intact animal, we
used in vivo microdialysis to determine changes in concentrations of DA in striatal dialysates from
freely moving adult male rats after exposure to 25 mg/kg/day Aroclor 1254 for varying periods of
time. We also determined DA concentrations in striatal tissue obtained postmortem from simi-
larly treated animals. The effects of PCBs on dialysate DA concentrations depended on the length
of exposure; DA concentrations were signiﬁcantly elevated after 3 days of exposure and were sig-
niﬁcantly reduced after exposure for periods of 1 week or longer. On the other hand, striatal tissue
concentrations of DA, determined postmortem in rats exposed to PCBs for the same periods of
time, were not signiﬁcantly altered. We suggest that these time-dependent alterations in dialysate
DA concentrations a) reﬂect PCB-induced alterations of both plasma membrane and vesicular DA
transporter function; b) provide a more sensitive index of altered central DA function after expo-
sure to PCBs than does measurement of postmortem tissue DA concentrations; and c) play an
important role in mediating some PCB-mediated changes in behavior. Key words: brain,
dopamine, in vivo, microdialysis, polychlorinated biphenyls, striatum. Environ Health Perspect
110:1113–1117 (2002). [Online 18 September 2002]
http://ehpnet1.niehs.nih.gov/docs/2002/110p1113-1117seegal/abstract.htmlpostmortem striatal tissue DA concentrations.
PCB exposure was continued until the day
microdialysis was conducted for all animals.
Thus, except for those exposed to either PCBs
or corn oil for 3 days, exposure to either PCBs
or corn oil began before surgical implantation
of the guide cannula. An experimental time
line of the relationship between PCB exposure,
surgical implantation of a guide cannula, and
microdialysis is presented in Figure 1.
Surgical procedures for microdialysis. All
surgical and postoperative procedures were
approved by the Institutional Animal Care and
Use Committee of the Wadsworth Center.
Adult male rats were anesthetized (65 mg/kg
sodium pentobarbital, intraperitoneally) and
placed in a Kopf model 900 stereotaxic instru-
ment (David Kopf Instruments, Tujunga,
CA). Using the stereotaxic atlas of Pellegrino et
al. (1981), we lowered a guide cannula into the
striatum using the following coordinates:
anterior–posterior, +2.4 mm; lateral, +3.0 mm
(both with respect to bregma); and dorsal–ven-
tral, –3.0 mm, with respect to the brain sur-
face. The guide cannula was attached to the
skull using dental acrylic anchored by several
small stainless steel screws embedded in the
skull. Postoperative pain was minimized by
administration of two intramuscular injections
of 0.2 mg/kg Torbugesic-SA (butorphanol tar-
trate; Fort Dodge Animal Health, Fort Dodge,
IA) at 4–6-hr intervals. All animals were
observed on a daily basis and were allowed a
5–7-day recovery period before insertion of the
microdialysis probe.
Microdialysis procedures. On the after-
noon before microdialysis, animals were
anesthetized intraperitoneally using 35–50
mg/kg of Brevital (methohexital sodium;
Jones Pharma, Inc., St. Louis, MO), a short-
acting anesthetic agent. A CMA12 micro-
dialysis probe (CMA/Microdialysis, North
Chelmsford, MA) with a 3-mm dialysis-
probe length was inserted into the guide can-
nula, and the animal was placed in a circular
cage fitted with a commercially available
counterweighted liquid swivel (Instech
Laboratories, Inc., Plymouth Meeting, PA).
Artiﬁcial cerebrospinal ﬂuid (148 mM NaCl,
4 mM KCl, 2.4 mM CaCl2·2H2O) was
pumped through the probe at a rate of 0.5
µL/min overnight, and food and water were
provided ad libitum. The next morning, the
ﬂow rate was increased to 1 µL/min, and 30-
min dialysate samples were collected for neu-
rochemical analyses. Each dialysate sample
was collected in a sample tube containing 3
µL of a preservative consisting of 2.2 N per-
chloric acid containing 150 µM Na2EDTA
and 290 µM Na2S2O5 and was immediately
stored at 4°C until analysis later that day.
Determination of striatal tissue DA con-
centrations. After sacriﬁce, using institution-
ally approved procedures, brains were rapidly
removed, rinsed with ice-cold saline, blotted,
quickly frozen on powdered dry ice, wrapped
tightly in aluminum foil, and maintained at
–80°C until dissection and subsequent neuro-
chemical analysis. For the micropunch brain
dissection technique, the brains were brought
to –10°C and mounted using TissueTek
(Sakura Finetek U.S.A., Inc., Torrance, CA)
on an aluminum chuck maintained on dry
ice. Brain tissue was cut into 750-µm-thick
sections, mounted on glass slides, and placed
on powdered dry ice. Tissue punches 1.6 mm
in diameter were obtained from the striatum
using the atlas of Palkovits and Brownstein
(1988). Tissue punches were homogenized in
150 µL of 0.2 N perchloric acid containing
100 mg/L EGTA using an ultrasonic homog-
enizer and centrifuged in a microcentrifuge
for 60 sec at 2–4°C. Homogenates were
frozen at –80°C until the time of analysis
(within 2 weeks).
HPLC analysis of DA. Concentrations
of DA, in either microdialysates or perchlo-
ric acid supernatants of striatal tissue
homogenates, were determined using chro-
matographic separation methods developed
and/or modified in our laboratory (Bemis
and Seegal 1999; Nakamura et al. 1992;
Seegal et al. 1986a). Aliquots (20 µL) of stri-
atal microdialysates or of a 1:10 dilution of
striatal tissue homogenates were injected via a
Waters 717 refrigerated autosampler (Waters
Corp., Milford, MA) onto a SUPELCOSIL
LC-18-DB 25 cm × 4.6 mm, 5-µm C18
reverse-phase column (Supelco, Bellefonte,
PA) maintained at 35°C. DA was quantiﬁed
using a BAS LC-4C amperometric detector
(BioAnalytical Systems, Inc., West Lafayette,
IN). Each chromatogram was stored digi-
tally, individually reviewed, and analyzed
using Waters Millennium Chromatography
Manager Software (Waters Corp.). Data
from the animals that underwent microdialy-
sis were expressed as nanograms of DA per
collection period and were corrected for
probe efficiency (Kehr 1993), and the post-
mortem tissue DA content was expressed as
nanograms per milligram of protein, deter-
mined by the method of Lowry et al. (1951).
Statistical procedures. Two-way analysis
of variance (ANOVA) with post hoc t-tests
was used to determine the signiﬁcance of dif-
ferences in the body weights of control ani-
mals and animals exposed to PCBs for 3 days
or for 1, 2, or 8 weeks.
For the microdialysis experiments, the
data from control animals at the different
exposure times were combined because there
were no statistical differences between control
animals at any of the exposure periods. The
effects of exposure to Aroclor 1254 on
dialysate DA concentrations were initially ana-
lyzed using a three-way ANOVA, which
examined the effects of PCBs and duration of
exposure (both between-subject variables), as
well as the within-subject repeated measure of
the four collection periods. Because the three-
way analysis does not permit determination of
which durations of exposure to PCBs differ
from controls, we also carried out separate
two-way ANOVAs (with repeated measures
for the four 30-min collections) for each expo-
sure duration (i.e., 3 days or 1, 2, or 8 weeks).
One-way ANOVAs were used to determine
the effects of PCB exposure on postmortem
striatal tissue concentrations of DA.
Results
Effects of PCB exposure on body weight. The
effects of daily exposure to 25 mg/kg Aroclor
1254 on body weights of adult male rats are
shown in Figure 2. Only after 8 weeks of
exposure to PCBs were there significant dif-
ferences in body weight between PCB-
exposed and control animals [t = 5.97,
degrees of freedom (df) = 17, p ≤ 0.001].
Effects of PCB exposure on dialysate DA
concentrations. The three-way ANOVA failed
to show a significant main effect of PCBs
(because of the initial increase in dialysate DA
seen at 3 days, followed by later reductions).
However, the two-way interaction term of
PCB × exposure duration was signiﬁcant (F =
5.46, df = 3,18, p < 0.01), demonstrating that
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Figure 1. Experimental time line of the relationship
between PCB exposure, surgical implantation of a
guide cannula, and microdialysis.
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Figure 2. Body weights of animals used for micro-
dialysis and striatal punch experiments. Control
animals and animals exposed to 25 mg/kg/day
Aroclor 1254 were sacriﬁced for experimental time
points at 3 days or at 1, 2, or 8 weeks. n = 7–11 ani-
mals/condition. Error bars indicate SE.
*p ≤ 0.001, post hoc t-test comparing PCB-exposed and
control animals.dialysate DA concentrations depended on the
duration of exposure to PCBs.
Subsequent two-way ANOVAs demon-
strated that the effects of exposure to Aroclor
1254 on dialysate DA concentrations sup-
ported that ﬁnding. Exposure for 3 days sig-
niﬁcantly increased (F = 13.12, df = 1,15, p ≤
0.01) dialysate DA concentrations compared
with control animals (Figure 3), whereas
exposure for longer periods of time signifi-
cantly decreased dialysate DA concentrations
(1 week: F = 5.75, df = 1,14, p ≤ 0.05; 2
weeks: F = 9.85, df = 1,14, p ≤ 0.01; 8 weeks:
F = 5.35, df = 1,14, p ≤ 0.05; Figure 3).
Effects of PCB exposure on striatal tissue
DA concentrations. Striatal tissue DA con-
centrations, determined postmortem in rats
exposed to PCBs for the same periods of
time as animals that underwent in vivo
microdialysis, were not significantly altered
after exposure to Aroclor 1254 at any of the
time points examined (Figure 4).
Discussion
Our major finding in this study was that
exposure of the adult rat to fairly low concen-
trations of PCBs signiﬁcantly altered dialysate
(extraneuronal) DA concentrations—increas-
ing DA concentrations after 3 days and
decreasing DA concentrations after longer
periods of exposure—without altering tissue
DA concentrations. These results demon-
strate that a) the mature central nervous sys-
tem may be more sensitive to PCBs than
previously thought; b) in vivo microdialysis
provides a more sensitive measure of PCB-
induced change in DA function than does
measurement of tissue DA concentrations;
and c) changes in dialysate DA concentrations
depend on the duration of exposure to PCBs.
The elevations in dialysate DA concentra-
tions seen here are strikingly similar to those
seen in media DA concentrations after acute ex
vivo exposure of adult rat striatal tissue to
Aroclor mixtures (Bemis and Seegal 1999;
Chishti et al. 1996) and are likely to reflect
similar mechanisms. Indeed, in those reports,
we suggested that the elevations in media DA
may have been due to PCB-induced inhibition
of DA transporters. The short-term elevation
in dialysate DA concentrations most likely
involves PCB-induced inhibition of the DAT
because drug-induced DAT inhibition signiﬁ-
cantly elevates dialysate DA concentrations in
rat striatum (Nakachi et al. 1995), whereas
pharmacologic inhibition of the vesicular
monoamine transporter (VMAT) has little or
no consequences on DA overflow in striatal
slices (Jones et al. 1998). However, it is per-
haps premature to rule out other mechanisms
that may occur in vivo and that may involve
either inhibition of DA uptake into intraneu-
ronal vesicles (Mariussen et al. 1999) (leading
to elevations in cytosolic free DA) or PCB-
induced elevations in intracellular calcium
concentrations (Kodavanti et al. 1996). In
turn, elevations in intracellular calcium
enhance exocytotic release of vesicular DA
(Bonanno et al. 2000) into the extraneuronal
space, further elevating extraneuronal DA due
initially to DAT inhibition.
We suggest that the long-term decreases in
striatal dialysate DA concentrations may be a
consequence of PCB-induced elevations in
both dialysate and cytosolic DA concentrations
for two reasons. First, elevations in extraneu-
ronal DA (seen here at 3 days and most likely
due to DAT inhibition) activate synthesis reg-
ulating autoreceptors, partially inhibiting de
novo DA synthesis (Wolf and Roth 1990) and
thus reducing the pool of DA available for
release. Second, elevations in free cytosolic DA,
measured as increases in dialysate DOPAC
(3,4-dihydroxyphenylacetic acid) concentra-
tions, (Teng et al. 1997; Zetterstrom et al.
1988), and most likely due to VMAT inhibi-
tion, may further contribute to reductions in
de novo synthesis of DA by altering the afﬁnity
of tyrosine hydroxylase (TH) for its cofactor,
tetrahydrobiopterin (Cooper et al. 1996;
Minami et al. 1992).
The rapid changes in dialysate DA con-
centrations (which may have occurred even
earlier than we measured) suggest that, at
least for the adult rodent, this widely dis-
persed environmental neurotoxicant may
have “pharmacologic” properties (i.e., PCBs
may induce changes in neurochemical func-
tion on a time scale similar to that of some
neuroactive drugs). Indeed, the biphasic
changes in dialysate DA concentrations after
Articles • PCBs alter extraneuronal DA
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Figure 3. Effects of Aroclor 1254 on extracellular DA concentrations in controls or in animals exposed to 25
mg/kg/day Aroclor 1254 (PCB) for (A) 3 days (p ≤ 0.01), or for (B) 1 week (p ≤ 0.05), (C) 2 weeks (p ≤ 0.01), or
(D) 8 weeks (p ≤ 0.05) prior to microdialysis. Four microdialysates (30 min/sample) were collected from
each animal; n = 3–13 animals/condition. Data are expressed as nanograms of DA per 30-min collection
interval, corrected for microdialysis probe efﬁciency. Data were analyzed at each exposure interval using
two-way ANOVA with repeated measures for the collections. Error bars indicate SE. 
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Figure 4. DA concentrations in striatal brain
micropunches from controls or from animals
exposed to 25 mg/kg/day Aroclor 1254 for 3 days or
for 1, 2, or 8 weeks. n = 4–7 animals/condition. Error
bars indicate SE. 
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PCBexposure to PCBs—in terms of both timing
and magnitude—are strikingly similar to the
changes seen by Imperato et al. (1996) after
subchronic exposure to d-amphetamine
(d-AMPH). The short-term elevations in
d-AMPH–induced dialysate DA concentra-
tions are likely to be mediated by mechanisms
similar to those by which PCBs elevate media
or extraneuronal concentrations of DA (i.e.,
VMAT and DAT inhibition). Thus, Jones et
al. (1998) demonstrated that ex vivo exposure
of striatal slices to d-AMPH resulted in
VMAT inhibition, reversal of normal DAT
function (i.e., transport of cytosolic DA into
the extracellular space), and enhanced release
of DA into media. However, at present there
is no evidence suggesting that PCBs reverse
DAT function.
The rapid changes in dialysate DA concen-
trations after exposure of the intact adult rat to
relatively modest levels of PCBs stand in sharp
contrast to the longer periods of time and
higher concentrations of PCBs required to
induce signiﬁcant changes in tissue DA con-
centrations (Seegal et al. 1986b, 1991).
Although seemingly counterintuitive, there are
several likely explanations for the lack of effect
of PCBs on tissue DA concentrations seen
here. First, the dose of PCBs used in this study
is considerably smaller than that used in other
studies that have demonstrated reductions in
brain DA concentrations in adult rats exposed
to PCBs (Seegal et al. 1991). Second, the lack
of discernible effect of PCBs on tissue DA con-
centrations may in part be because of the exis-
tence of two pools of DA—a readily releasable
pool (RRP) of DA replenished by de novo syn-
thesis and a larger, non-readily releasable stor-
age pool (Chiueh and Moore 1975; Kuczenski
1977; Yavich and MacDonald 2000) [esti-
mates of the size of the RRP of DA vary
between 5% and 20% of total DA (Javoy and
Glowinski 1971; Yavich 1996)]. Because tissue
DA includes contributions from both pools
while extraneuronal DA reflects changes in
only the RRP of DA, the consequences of
PCB exposure would be more apparent in the
smaller pool. Furthermore, PCB-induced inhi-
bition of DA synthesis (due either to activation
of inhibitory autoreceptors or end-product
inhibition due to elevations in cytosolic DA)
would have consequences primarily on the
RRP because the vesicular content of the RRP
of DA under unstimulated conditions is
replenished with DA that is either newly syn-
thesized or recently taken up from the extra-
neuronal space by the DAT (Javoy and
Glowinski 1971; McMillen et al. 1980).
Finally, PCB-induced VMAT inhibition is
more likely to reduce DA concentrations in
the RRP than in the larger storage pool
because of the higher turnover of DA (i.e.,
release and reuptake) in the RRP (McMillen
et al. 1980).
There are several possible consequences of
the PCB-induced inhibition of DA trans-
porters. First, increased cytosolic concentra-
tions of free DA (i.e., that not stored in
vesicles and due to VMAT inhibition)
enhance both enzymatic and nonenzymatic
degradation of DA, leading to an increase in
the formation of reactive DA metabolites
(LaVoie and Hastings 1999), including
quinones and semiquinones shown to inhibit
DAT function (Berman et al. 1996). These
quinones, as well as other free radicals (Voie
and Fonnum 2000), including hydrogen per-
oxide (Miller et al. 1996), may ultimately
lead to an increased likelihood of free radical-
induced neuronal damage. However, at the
doses and durations of exposure employed in
this study, it is unlikely that the PCBs lead
to neuronal death because a) tissue DA con-
centrations were not altered and b) lactate
dehydrogenase levels were unaffected in
organotypic striatal slice preparations from
adult rats exposed to higher concentrations
of PCBs than used here (Bemis and Seegal
1999). Second, a reduction in the vesicular
concentration of DA [similar to that seen by
Jones et al. (1998) and Imperato et al. (1996)
after long-term exposure to d-AMPH] may
result in a decrease in the amount of DA
released after depolarization of the neuron,
thereby altering the normal transfer of infor-
mation between neurons.
Although these studies were undertaken in
the adult animal, they may ultimately aid in
furthering our understanding of some of the
mechanisms by which developmental expo-
sure to PCBs alters neuronal function. Before
this study, the effects of PCBs on in vivo DA
function were estimated by measuring either
tissue DA concentrations (Seegal et al. 1986b,
1991) or TH (Kodavanti et al. 1998; Seegal et
al. 1994). Indeed, Kodavanti et al. (1998)
exposed adult rats to concentrations of PCBs
similar to those used here but were unable to
detect differences in either tissue DA concen-
trations or TH immunoreactivity. These ﬁnd-
ings raise the toxicologically important
question of whether the disparity between the
concentrations of PCBs needed to alter neuro-
chemical function and those required to alter
some behaviors may reﬂect the earlier meth-
ods used to assess central DA function, which
we have shown to be relatively insensitive.
In conclusion, the results that we obtained
using in vivo microdialysis demonstrate that
changes in adult striatal dialysate DA occur at
much earlier times and at signiﬁcantly lower
doses of PCBs than do changes in adult striatal
tissue DA content determined postmortem.
Furthermore, we suggest that the PCB-
induced changes in dialysate DA concentra-
tions are strikingly similar to those seen after
exposure to d-AMPH. Thus, cognitive deﬁcits,
including decreased attention span, that are
purported to be due to developmental expo-
sure to PCBs may, in part, be due to alter-
ations in DA function similar to those that
induce deﬁcits in infants and children develop-
mentally exposed to stimulant drugs of abuse.
REFERENCES
Arnsten AF. 1997. Catecholamine regulation of the prefrontal
cortex. J Psychopharmacol 11:151–162.
Bemis JC, Seegal RF. 1999. Polychlorinated biphenyls and
methylmercury act synergistically to reduce rat brain
dopamine content in vitro. Environ Health Perspect
107:879–885.
Berman SB, Zigmond MJ, Hastings TG. 1996. Modification of
dopamine transporter function: effect of reactive oxygen
species and dopamine. J Neurochem 67:593–600.
Bonanno G, Sala R, Cancedda L, Cavazzani P, Cossu P, Raiteri
M. 2000. Release of dopamine from human neocortex
nerve terminals evoked by different stimuli involving
extra- and intraterminal calcium. Br J Pharmacol
129:1780–1786.
Chishti MA, Fisher JP, Seegal RF. 1996. Aroclors 1254 and 1260
reduce dopamine concentrations in rat striatal slices.
Neurotoxicology 17:653–660.
Chiueh CC, Moore KE. 1975. d-Amphetamine-induced release of
“newly synthesized” and “stored” dopamine from the cau-
date nucleus in vivo. J Pharmacol Exp Ther 192:642–653.
Cooper JR, Bloom FE, Roth RH. 1996. Dopamine. In: The
Biochemical Basis of Neuropharmacology. New
York:Oxford University Press, 293–351.
Eriksson P. 1998. Perinatal Developmental Neurotoxicity of
PCBs. Report No. 4897. Stockholm:Swedish Environmental
Protection Agency.
Goldey ES, Kehn LS, Lau C, Rehnberg GL, Crofton KM. 1995.
Developmental exposure to polychlorinated biphenyls
(Aroclor 1254) reduces circulating thyroid hormone con-
centrations and causes hearing deficits in rats. Toxicol
Appl Pharmacol 135:77–88.
Imperato A, Obinu MC, Carta G, Mascia MS, Casu MA, Gessa
GL. 1996. Reduction of dopamine release and synthesis by
repeated amphetamine treatment: role in behavioral sen-
sitization. Eur J Pharmacol 317:231–237.
Jacobson JL, Jacobson SW. 1996. Intellectual impairment in
children exposed to polychlorinated biphenyls in utero. N
Engl J Med 335:783–789.
Javoy F, Glowinski J. 1971. Dynamic characteristic of the
‘functional compartment’ of dopamine in dopaminergic
terminals of the rat striatum. J Neurochem 18:1305–1311.
Jones SR, Gainetdinov RR, Wightman RM, Caron MG. 1998.
Mechanisms of amphetamine action revealed in mice lack-
ing the dopamine transporter. J Neurosci 18:1979–1986.
Kehr J. 1993. A survey on quantitative microdialysis: theoreti-
cal models and practical implications. J Neurosci
Methods 48:251–261.
Kodavanti PR, Derr-Yellin EC, Mundy WR, Shafer TJ, Herr DW,
Barone S, et al. 1998. Repeated exposure of adult rats to
Aroclor 1254 causes brain region-specific changes in
intracellular Ca2+ buffering and protein kinase C activity in
the absence of changes in tyrosine hydroxylase. Toxicol
Appl Pharmacol 153:186–198.
Kodavanti PRS, Ward TR, McKinney JD, Tilson HA. 1996.
Inhibition of microsomal and mitochondrial Ca2+-seques-
tration in rat cerebellum by polychlorinated biphenyl mix-
tures and congeners: structure-activity relationships.
Arch Toxicol 70:150–157.
Kuczenski R. 1977. Differential effects of reserpine and tetra-
benazine on rat striatal synaptosomal dopamine biosyn-
thesis and synaptosomal dopamine pools. J Pharmacol
Exp Ther 201:357–367.
LaVoie MJ, Hastings TG. 1999. Dopamine quinone formation
and protein modiﬁcation associated with the striatal neu-
rotoxicity of methamphetamine: evidence against a role
for extracellular dopamine. J Neurosci 19:1484–1491.
Lowry OH, Rosebrough NJ, Farr AL, Randall RJ. 1951. Protein
measurement with the Folin phenol reagent. J Biol Chem
193:265–275.
Mariussen E, Andersen JM, Fonnum F. 1999. The effect of poly-
chlorinated biphenyls on the uptake of dopamine and
other neurotransmitters into rat brain synaptic vesicles.
Toxicol Appl Pharmacol 161:274–282.
Mariussen E, Fonnum F. 2001. The effect of polychlorinated
Articles • Seegal et al.
1116 VOLUME 110 | NUMBER 11 | November 2002 • Environmental Health Perspectivesbiphenyls on the high afﬁnity uptake of the neurotransmit-
ters, dopamine, serotonin, glutamate and GABA, into rat
brain synaptosomes. Toxicology 159:11–21.
McMillen BA, German DC, Shore PA. 1980. Functional and phar-
macological significance of brain dopamine and norepi-
nephrine storage pools. Biochem Pharmacol 29:3045–3050.
Messeri MD, Bickmeyer U, Weinsberg F, Wiegand H. 1997.
Congener speciﬁc effects by polychlorinated biphenyls on
catecholamine content and release in chromaffin cells.
Arch Toxicol 71:416–421.
Miller JW, Selhub J, Joseph JA. 1996. Oxidative damage
caused by free radicals produced during catecholamine
autoxidation: protective effects of O-methylation and
melatonin. Free Radic Biol Med 21:241–249.
Minami M, Takahashi T, Maruyama W, Takahashi A, Dostert
P, Nagatsu T, et al. 1992. Inhibition of tyrosine hydroxy-
lase by R and S enantiomers of salsolinol, 1-methyl-6,7-
dihydroxy-1,2,3,4-tetrahydroisoquinoline. J Neurochem
58:2097–2101.
Nakachi N, Kiuchi Y, Inagaki M, Inazu M, Yamazaki Y, Oguchi
K. 1995. Effects of various dopamine uptake inhibitors on
striatal extracellular dopamine levels and behaviors in
rats. Eur J Pharmacol 281:195–203.
Nakamura S, Goshima Y, Yue J-L, Misu Y. 1992. Transmitter-
like basal and K+-evoked release of 3,4-dihydroxypheny-
lalanine from the striatum in conscious rats studied by
microdialysis. J Neurochem 58:270–275.
O’Keefe PW, Smith RM, Hilker DR, Aldous KM, Gilday W. 1985.
A semiautomated cleanup method for polychlorinated
dibenzo-p-dioxins and polychlorinated dibenzofurans in
environmental samples. In: Chlorinated Dioxins and
Dibenzofurans in the Total Environment II (Keith L, Rappe
C, Choudhury G, eds). Woburn, MA:Butterworth, 111–124.
Palkovits M, Brownstein MJ. 1988. Maps and Guide to
Microdissection of the Rat Brain. New York:Elsevier.
Patandin S, Lanting CI, Mulder PGH, Boersma ER, Sauer PJ,
Weisglas-Kuperus N. 1999. Effects of environmental expo-
sure to polychlorinated biphenyls and dioxins on cognitive
abilities in Dutch children at 42 months of age. J Pediatr
134:33–41.
Pellegrino LJ, Pellegrino AS, Cushman AJ. 1981. A Stereotaxic
Atlas of the Rat Brain. New York:Plenum Press.
Roegge CS, Seo BW, Crofton KM, Schantz SL. 2000.
Gestational-lactational exposure to Aroclor 1254 impairs
radial-arm maze performance in male rats. Toxicol Sci
57:121–130.
Rosin DL, Martin BR. 1981. Neurochemical and behavioral effects
of polychlorinated biphenyls in mice. Neurotoxicology
2:749–764.
Seegal RF, Brosch KO, Bush B. 1986a. High-performance liquid
chromatography of biogenic amines and metabolites in
brain, cerebrospinal ﬂuid, urine and plasma. J Chromatogr
377:131–144.
———. 1986b. Polychlorinated biphenyls produce regional
alterations of dopamine metabolism in rat brain. Toxicol
Lett 30:197–202.
Seegal RF, Brosch KO, Okoniewski RJ. 1997. Effects of in utero
and lactational exposure of the laboratory rat to 2,4,2´,4´-
and 3,4,3´,4´-tetrachlorobiphenyl on dopamine function.
Toxicol Appl Pharmacol 146:95–103.
Seegal RF, Bush B, Brosch KO. 1991. Sub-chronic exposure of
the adult rat to Aroclor 1254 yields regionally-specific
changes in central dopaminergic function. Neurotoxicology
12:55–66.
Seegal RF, Chishti MA, Turner JN, Roysam B, Ancin H. 1994.
PCBs reduce the number of dopaminergic neurons in rat
substantia nigra determined by laser-scanning confocal
microscopy. Toxicologist 14:353.
Shain W, Bush B, Seegal RF. 1991. Neurotoxicity of polychlori-
nated biphenyls: structure-activity relationship of individ-
ual congeners. Toxicol Appl Pharmacol 111:33–42.
Sokolowski JD, Salamone JD. 1994. Effects of dopamine deple-
tions in the medial prefrontal cortex on DRL performance
and motor activity in the rat. Brain Res 642:20–28.
Stewart P, Reihman J, Lonky E, Darvill T, Pagano J. 2000. Prenatal
PCB exposure and neonatal behavioral assessment scale
(NBAS) performance. Neurotoxicol Teratol 22:21–29.
Teng L, Crooks PA, Sonsalla PK, Dwoskin LP. 1997. Lobeline
and nicotine evoke [3H]overflow from rat striatal slices
preloaded with [3H]dopamine: differential inhibition of
synaptosomal and vesicular [3H]dopamime uptake. J
Pharmacol Exp Ther 280:1432–1444.
Voie ØA, Fonnum F. 2000. Effect of polychlorinated biphenyls
on production of reactive oxygen species (ROS) in rat
synaptosomes. Arch Toxicol 73:588–593.
Wolf ME, Roth RH. 1990. Autoreceptor regulation of dopamine
synthesis. Ann NY Acad Sci 604:323–343.
Yavich L. 1996. Two simultaneously working storage pools of
dopamine in mouse caudate and nucleus accumbens. Br
J Pharmacol 119:869–876.
Yavich L, MacDonald E. 2000. Dopamine release from pharma-
cologically distinct storage pools in rat striatum following
stimulation at frequency of neuronal bursting. Brain Res
870:73–79.
Zetterstrom T, Sharp T, Collin AK, Ungerstedt U. 1988. In vivo
measurement of extracellular dopamine and DOPAC in rat
striatum after various dopamine-releasing drugs; implica-
tions for the origin of extracellular DOPAC. Eur J Pharmacol
148:327–334.
Articles • PCBs alter extraneuronal DA
Environmental Health Perspectives • VOLUME 110 | NUMBER 11 | November 2002 1117